Inovio Pharmaceuticals, Inc.
INO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $65,813 | $14,311 | $46,329 | $71,144 |
| Short-Term Investments | $28,300 | $130,983 | $206,669 | $330,171 |
| Receivables | $1,199 | $2,405 | $11,738 | $8,032 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,517 | $5,414 | $50,506 | $39,098 |
| Total Curr. Assets | $97,830 | $153,113 | $315,243 | $448,445 |
| Property Plant & Equip (Net) | $11,774 | $14,453 | $17,956 | $29,024 |
| Goodwill | $0 | $0 | $10,513 | $10,513 |
| Intangibles | $0 | $0 | $2,130 | $2,626 |
| Long-Term Investments | $1,614 | $2,780 | $2,007 | $3,907 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,980 | $605 | $684 | $1,426 |
| Total NC Assets | $15,367 | $17,838 | $33,291 | $47,497 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $113,197 | $170,951 | $348,533 | $495,941 |
| Liabilities | – | – | – | – |
| Payables | $6,443 | $4,648 | $21,083 | $27,973 |
| Short-Term Debt | $2,497 | $19,177 | $2,804 | $2,604 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $22 |
| Other Curr. Liab. | $26,386 | $18,745 | $72,981 | $35,143 |
| Total Curr. Liab. | $35,326 | $42,570 | $96,868 | $65,742 |
| LT Debt | $9,368 | $11,032 | $29,270 | $30,419 |
| Deferred Rev, NC | $0 | $0 | $0 | $64 |
| Deferred Tax Liab, NC | $0 | $0 | $32 | $32 |
| Other NC Liab. | $0 | $0 | $0 | $15 |
| Total NC Liab. | $9,368 | $11,032 | $29,302 | $30,530 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11,865 | $13,439 | $15,460 | $18,064 |
| Total Liabilities | $44,693 | $53,602 | $126,171 | $96,272 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $36 | $23 | $21 | $217 |
| Retained Earnings | -$1,730,219 | -$1,622,965 | -$1,487,848 | -$1,209,856 |
| AOCI | -$676 | -$663 | -$699 | -$282 |
| Other Equity | $1,799,363 | $1,740,954 | $1,710,888 | $1,609,590 |
| Total Equity | $68,504 | $117,349 | $222,363 | $399,669 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $113,197 | $170,951 | $348,533 | $495,941 |
| Net Debt | -$53,948 | $15,898 | -$14,255 | -$38,121 |